Improved
Diagnosis of Amyotrophic Lateral Sclerosis by Transcranial Magnetic Stimulation in a
Routine Clinical Setting Johannes
C. WSS. Adohrle, Konstantinos Spengos, Wolfgang Steinke, Michael Hennerici
Tuesday 4:00:00 PM / Room 309
OBJECTIVE:
To demonstrate upper motor neuron dysfunction in amyotrophic lateral sclerosis (ALS) by
transcranial magnetic stimulation (TMS) in a routine clinical setting.
BACKGROUND:
Central motor conduction times (CMCT) have been shown to be prolonged in ALS, but the
diagnostic yield of TMS in patients without definite upper motor neuron signs (UMNS), like
obvious spasticity or Babinsky´s sign, is less clear.
DESIGN/METHODS:
In 22 consecutive patients, we diagnosed classic ALS, ALS with probable UMNS, and
progressive bulbar palsy, based on clinical and electromyographic evidence, imaging
studies and subsequent clinical course. Shortly after initial diagnosis, we obtained motor
evoked potentials in the first dorsal interosseous and anterior tibial muscles by TMS
using a standard protocol, and compared CMCT and clinical findings.
RESULTS:
Overall, 8 of 22 patients had definite UMNS of whom 7 revealed a prolonged CMCT in at
least one limb, however, CMCT was also prolonged in 8 of 14 patients without definite
UMNS. Among the 15 patients with a disease duration of less than 12 months at the time of
TMS, were 10 patients with progressive bulbar palsy of whom 4 patients without definite
UMNS demonstrated a pathological CMCT. In the other 5 ALS patients, TMS findings
correlated exactly with definite (3) or only probable (2) UMNS. In 7 ALS patients with
symptoms for 12 months or more, TMS demonstrated upper motor neuron involvement in 4 of 6
patients without definite UMNS.
CONCLUSIONS:
Transcranial magnetic stimulation demonstrated upper motor neuron dysfunction in more than
half of our patients without definite clinical pyramidal tract signs. It was also useful
early in progressive bulbar palsy presenting without definite UMNS. In ALS without
definite UMNS of 12 months duration or more, TMS revealed subclinical upper motor neuron
involvement in the majority of patients, thus providing further evidence of the diagnosis.
|